Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploring the Efficacy and Safety of Dapagliflozin in Improving Heart Failure in Dialysis Patients: an Open, Prospective, and Self-controlled Study

NCT06365541 is registered in ClinicalTrials.gov with The People's Hospital of Gaozhou as lead sponsor.

NCT NCT06365541
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06365541 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploring the Efficacy and Safety of Dapagliflozin in Improving Heart Failure in Dialysis Patients: an Open, Prospective, and Self-controlled Study
Lead sponsor
The People's Hospital of Gaozhou
Phase
Phase 4
Overall status
Unknown status
Start date
March 1, 2024
Completion date
August 31, 2024
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

the efficacy and safety of dapagliflozin in improving heart failure in dialysis patients